API
GILD icon

Advisor Partners II’s Gilead Sciences GILD Stock Holding History

Advisor Partners II’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$3.89M Buy
51,953
+3,886
+8% +$299K 0.16% 136
2023
Q2 		$3.7M Buy
48,067
+5,384
+13% +$429K 0.17% 110
2023
Q1 		$3.54M Buy
42,683
+3,935
+10% +$326K 0.2% 101
2022
Q4 		$3.33M Buy
38,748
+4,106
+12% +$325K 0.21% 99
2022
Q3 		$2.14M Buy
+34,642
New +$2.18M 0.16% 130

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Advisor Partners II's GILD Position: Q3 2023 in Review

Advisor Partners II increased its Gilead Sciences (GILD) stake by 8.1% in Q3 2023, buying an estimated $299K and bringing the position to 51,953 shares worth $3.89M. The position accounts for 0.16% of the portfolio, ranked #136.

Advisor Partners II first reported a position in GILD in Q3 2022 and has held it in 5 quarters since. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

  • Advisor Partners II held 51,953 shares of Gilead Sciences worth $3.89M as of Q3 2023.
  • Advisor Partners II bought 3,886 Gilead Sciences shares in Q3 2023, an estimated $299K.
  • Gilead Sciences made up 0.16% of Advisor Partners II's portfolio in Q3 2023, its #136 holding.
  • Advisor Partners II first reported a position in Gilead Sciences in Q3 2022 and has held it in 5 quarters since.
  • 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.